Dr. Nachamkin to Chair ASM Ad Hoc Committee on Assessing Evidence-based Laboratory Medicine Practice Guidelines

December 18, 2014

Assessment of Laboratory Medicine Practice Guidelines is part of a cooperative agreement between the ASM and the CDC to the ensure the development of transparent, rigorous evidence-based guidelines.

Read more

Xu Lab Publishes in Nature Communications

December 16, 2014

New technique to repurpose fibroblasts into functional melanocytes.

Read more

Lambris Lab Demonstrates Way to Tame Inflammatory Response in Kidney Dialysis

December 11, 2014

"Therapeutic C3 inhibitor Cp40 abrogates complement activation induced by modern hemodialysis filters" published in Immunobiology. 

Read more

Latest Results of Investigational Cellular Therapy CTL019 at ASH

December 08, 2014

Highlights of the new trial results include a response rate of more than 90 percent among pediatric ALL patients, and results from the first lymphoma trials testing the approach, including a 100 percent response rate among follicular lymphoma patients and 45 percent response rate among those with diffuse large B cell lymphoma.

Read more

Dr. Malek Kamoun Elected President of ASHI

November 14, 2014

Dr. Kamoun assumes the 2014-15 Presidency of the American Society for Histocompatibility and Immunogenetics (ASHI).

Read more

Landmark Mitochondria Study Offers New Insights into Causes of Metabolic, Degenerative Diseases

October 30, 2014

Wallace Lab findings challenge the traditional “single mutation–single disease” concept and provide an alternative perspective into understanding the underlying cause of metabolic and neurodegenerative disorders.

Read more

DOD Grant for Lupus Research

October 29, 2014

Michael P. Cancro, PhD, is one of three recipients of grants totaling $3.4 million that have been awarded by the U.S. Department of Defense (DOD) for lupus research. 

Read more

$12 Million DARPA Award for Synthetic DNA Vaccines

October 20, 2014

The Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million for a project to develop DNA-based monoclonal antibodies (mAbs) for infectious disease treatment.

Read more

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

October 16, 2014

Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) who had relapsed multiple times or failed to respond to standard therapies went into remission after receiving an investigational personalized cellular therapy, CTL019, developed at the Perelman School of Medicine at the University of Pennsylvania. The unprecedented results are published this week in The New England Journal of Medicine.

Read more

2014 ASCP Annual Meeting Awards

October 13, 2014

Honors for Dr. Virginia LiVolsi, Dr. Zubair Baloch, and fourth-year resident Dr. Sam Wei.

Read more

Pages